Difference between revisions of "Zidovudine (Retrovir)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Adult T-cell leukemia/lymphoma" to "[[Category:Adult T-cell leukemia-lymphoma") |
m |
||
| Line 12: | Line 12: | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| − | [[Category:DNA synthesis inhibitors | + | [[Category:Viral DNA synthesis inhibitors]] |
| − | |||
[[Category:Adult T-cell leukemia-lymphoma medications]] | [[Category:Adult T-cell leukemia-lymphoma medications]] | ||
[[Category:FDA approved in 1987]] | [[Category:FDA approved in 1987]] | ||
Latest revision as of 18:20, 27 February 2020
Mechanism of action
From the NCI Drug Dictionary: A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zidovudine inhibits DNA polymerase, resulting in the inhibition of DNA replication and cell death. This agent also decreases levels of available pyrimidines.
Diseases for which it is used
Also known as
- Generic names: azidothymidine, AZT, ZDV
- Brand names: Aztec, Retrovir